Clearance Summary
LINISTAIN SLS received FDA 510(k) clearance under submission number K890984, sponsored by Shandon, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Pathology review panel. The statutory decision date of record is 1989-04-04.
- Submission: K890984
- Applicant / Sponsor: Shandon, Inc.
- Clearance pathway: Traditional
- Review panel: Pathology
- Device class: Class I
- Regulation citation: 21 CFR 864.3800
- Decision date: 1989-04-04
Classification & Regulation
This clearance is catalogued under FDA product code KIO and 21 CFR 864.3800, within the Pathology review panel as a Class I device.